Showing results (1-10 of 322) with videos related to
Sort By:
Pageof 33
Biological Chemistry|December 23, 2017
Metformin-induced anticancer activities: recent insightsStephen Safe, Vijayalekshmi Nair, Keshav KarkiMolecular Cancer Research : MCR|October 27, 2020
The Paradoxical Roles of Orphan Nuclear Receptor 4A (NR4A) in CancerStephen Safe, Keshav KarkiMolecular Pharmacology|August 18, 2018
Bortezomib Targets Sp Transcription Factors in Cancer CellsKeshav Karki, Sneha Harishchandra, Stephen SafeExpert Opinion on Therapeutic Targets|May 6, 2014
Transcription factor Sp1, also known as specificity protein 1 as a therapeutic targetStephen Safe, Parisa Imanirad, Sandeep Sreevalsan, et al.Gynecologic Oncology|May 5, 2019
Nuclear receptor 4A1 (NR4A1) antagonists induce ROS-dependent inhibition of mTOR signaling in endometrial cancerKumaravel Mohankumar, Xi Li, Subhashree Sridharan, et al.The Journal of Biological Chemistry|November 23, 2016
Benzyl Isothiocyanate (BITC) Induces Reactive Oxygen Species-dependent Repression of STAT3 Protein by Down-regulation of Specificity Proteins in Pancreatic CancerRavi Kasiappan, Indira Jutooru, Keshav Karki, et al.Biochemical and Biophysical Research Communications|May 15, 2018
Inhibition of pancreatic cancer Panc1 cell migration by omeprazole is dependent on aryl hydrocarbon receptor activation of JNKUn-Ho Jin, Keshav Karki, Sang-Bae Kim, et al.American Journal of Cancer Research|August 15, 2022
Short chain fatty acids exhibit selective estrogen receptor downregulator (SERD) activity in breast cancerAbigail Schoeller, Keshav Karki, Arul Jayaraman, et al.Cancer Prevention Research (Philadelphia, Pa.)|July 5, 2017
Piperlongumine Induces Reactive Oxygen Species (ROS)-Dependent Downregulation of Specificity Protein Transcription FactorsKeshav Karki, Erik Hedrick, Ravi Kasiappan, et al.Cancers|June 2, 2021
NR4A1 Ligands as Potent Inhibitors of Breast Cancer Cell and Tumor GrowthKeshav Karki, Kumaravel Mohankumar, Abigail Schoeller, et al.Pageof 33